The Melanoma Research Alliance (MRA) announces its seventh annual Request for Proposals (RFP), soliciting translational research grant applications from scientists and clinicians around the world. The RFP calls for ideas that could lead to high impact near-term clinical application in melanoma detection, prevention, diagnosis, staging, or treatment. MRA will accept proposals for Young Investigator Awards, Academic-Industrial Partnership Awards, Team Science Awards and Special Opportunity Awards for Israel-based investigators. During this 2014 grant cycle, the organization plans to award at least $8 million to new projects.
Melanoma is a leading cause of new cancers, and more effective options for early detection, prevention, diagnosis, and treatment are urgently needed. Recent scientific and clinical advances have provided new hope for patients, but much work remains to be done as MRA continues to work toward the day when no one will suffer or die from melanoma.
Please note the following key deadlines:
- Team Science Award Letters of Intent due October 7, 2013
- Israel Special Opportunity Award applications due October 14, 2013
- Young Investigator and Academic-Industry Partnership applications due November 13, 2013
Full descriptions of each opportunity including eligibility criteria and deadlines can be found in the RFP document below.
Questions: Laura Brockway-Lunardi, Ph.D., MRA Scientific Program Director, email@example.com